SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-065473
Filing Date
2014-11-06
Accepted
2014-11-06 08:10:28
Documents
11
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v392450_10q.htm 10-Q 309131
2 EXHIBIT 31.1 v392450_ex31-1.htm EX-31.1 8178
3 EXHIBIT 31.2 v392450_ex31-2.htm EX-31.2 8336
4 EXHIBIT 32.1 v392450_ex32-1.htm EX-32.1 4583
5 EXHIBIT 32.2 v392450_ex32-2.htm EX-32.2 4410
  Complete submission text file 0001144204-14-065473.txt   5022479

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cndo-20140930.xml EX-101.INS 779822
7 XBRL TAXONOMY EXTENSION SCHEMA cndo-20140930.xsd EX-101.SCH 37856
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cndo-20140930_cal.xml EX-101.CAL 34124
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cndo-20140930_def.xml EX-101.DEF 297345
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cndo-20140930_lab.xml EX-101.LAB 353652
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cndo-20140930_pre.xml EX-101.PRE 335968
Mailing Address 24 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 24 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 781-652-4500
CORONADO BIOSCIENCES INC (Filer) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35366 | Film No.: 141198898
SIC: 2834 Pharmaceutical Preparations